Authorized Generics: An Interim Report
http://www.ftc.gov/os/2009/06/P062105authorizedgenericsreport.pdf
Presents the first set of results from a study of the effects of authorized generic drugs on competition in the prescription drug marketplace. The initial analysis suggests that consumers benefit and the healthcare system saves money during the 180 day exclusivity period when an authorized generic enters the market. From the Federal Trade Commission.
Comments
Comments are not allowed for this entry.
